Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.76 |
| ▸ | HPGD | P15428 | 6/20 | 0.76 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.76 |
| ▸ | MAPT | P10636 | 4/20 | 0.76 |
| ▸ | MEN1 | O00255 | 4/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.76 |
| ▸ | TP53 | P04637 | 4/20 | 0.76 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.76 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.76 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.76 |
| ▸ | NPC1 | O15118 | 8/20 | 0.62 |
| ▸ | RAB9A | P51151 | 7/20 | 0.62 |
| ▸ | GAA | P10253 | 3/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | GFER | P55789 | 1/20 | 0.53 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22955330 | 0.97 | KDM4E (0.71) | KDM4EALDH1A1HPGDHSD17B10MAPT | |
| SCHEMBL15245092 | 0.97 | KDM4E (0.71) | KDM4EALDH1A1HPGDHSD17B10MAPT | |
| SCHEMBL9032997 | 0.91 | ALDH1A1 (0.62) | KDM4EALDH1A1HPGDHSD17B10MAPT | |
| SCHEMBL22956059 | 0.91 | KDM4E (0.63) | KDM4EALDH1A1HPGDHSD17B10MAPT | |
| SCHEMBL3335014 | 0.89 | ALDH1A1 (0.61) | KDM4EALDH1A1HPGDHSD17B10MAPT | |
| SCHEMBL3336441 | 0.88 | KDM4E (0.59) | KDM4EALDH1A1HPGDHSD17B10MAPT | |
| SCHEMBL22956044 | 0.87 | KDM4E (0.59) | KDM4EALDH1A1HPGDHSD17B10MAPT | |
| SCHEMBL29898236 | 0.86 | KDM4E (1.00) | KDM4EALDH1A1HPGDHSD17B10MAPT | |
| SCHEMBL8337597 | 0.86 | KDM4E (1.00) | KDM4EALDH1A1HPGDHSD17B10MAPT | |
| SCHEMBL1171146 | 0.85 | ALDH1A1 (0.53) | KDM4EALDH1A1HPGDHSD17B10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1891393-A | Preflux composition | BAIK YANG CHEMICAL CO LTD (KR) | 2007-01-10 | — | — | CN | claimed |
| US-20260125348-A1 | ARYL HYDROCARBON RECEPTOR ACTIVATORS | OREGON STATE UNIVERSITY (US) | 2026-05-07 | — | — | US | disclosed |
| EP-4710922-A2 | ARYL HYDROCARBON RECEPTOR ACTIVATORS | Oregon State University (US) | 2026-03-18 | — | — | EP | disclosed |
| EP-4003337-B1 | ARYL HYDROCARBON RECEPTOR ACTIVATORS | UNIV OREGON STATE (US) | 2026-03-11 | — | — | EP | disclosed |
| US-12473262-B2 | Aryl hydrocarbon receptor activators | OREGON STATE UNIVERSITY (US) | 2025-11-18 | — | — | US | disclosed |
| CN-116924995-A | Method for synthesizing benzimidazole compound by catalyzing L-phenylalanine | 宁夏师范学院 | 2023-10-24 | — | — | CN | disclosed |
| CN-110759903-B | Novel synthesis method of thiabendazole | 南开大学 | 2022-10-28 | — | — | CN | disclosed |
| US-20220281824-A1 | ARYL HYDROCARBON RECEPTOR ACTIVATORS | OREGON STATE UNIVERSITY (US) | 2022-09-08 | — | — | US | disclosed |
| EP-4003337-A1 | ARYL HYDROCARBON RECEPTOR ACTIVATORS | Oregon State University (US) | 2022-06-01 | — | — | EP | disclosed |
| CN-106802536-B | Transfer material, method for producing same, laminate, and method for producing same | 富士胶片株式会社 | 2022-03-04 | — | — | CN | disclosed |
| US-10157695-B2 | — | — | 2018-12-18 | — | — | US | disclosed |
| US-10059087-B2 | Transfer film, method for manufacturing transfer film, laminate, method for manufacturing laminate, capacitive input device, and image display device | FUJIFILM CORPORATION (JP) | 2018-08-28 | — | — | US | disclosed |
| CN-106802536-A | Transfer materials and its manufacture method, layered product and its manufacture method | 富士胶片株式会社 | 2017-06-06 | — | — | CN | disclosed |
| US-20170154704-A1 | TRANSFER MATERIAL, METHOD OF MANUFACTURING TRANSFER MATERIAL, LAMINATED BODY, METHOD OF MANUFACTURING LAMINATED BODY, METHOD OF MANUFACTURING CAPACITANCE-TYPE INPUT DEVICE, AND METHOD OF MANUFACTURING IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2017-06-01 | — | — | US | disclosed |
| CN-106660309-A | Transfer film, method for manufacturing transfer film, laminate, method for manufacturing laminate, capacitance-type input device, and image display device | 富士胶片株式会社 | 2017-05-10 | — | — | CN | disclosed |
| US-20170095999-A1 | TRANSFER FILM, METHOD FOR MANUFACTURING TRANSFER FILM, LAMINATE, METHOD FOR MANUFACTURING LAMINATE, CAPACITIVE INPUT DEVICE, AND IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2017-04-06 | — | — | US | disclosed |
| US-8198307-B2 | Imidazole derivatives having aryl piperidine substituent, method for preparation thereof and pharmaceutical compositions containing same | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2012-06-12 | — | — | US | disclosed |
| US-20100145054-A1 | IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2010-06-10 | — | — | US | disclosed |
| WO-2008140239-A1 | IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2008-11-20 | — | — | WO | disclosed |
| CN-1891393-A | Preflux composition | BAIK YANG CHEMICAL CO LTD (KR) | 2007-01-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220281824-A1 | ARYL HYDROCARBON RECEPTOR ACTIVATORS | AHR, ARNT, NR0B1 | KDM4E 2779/4885ALDH1A1 787/4885HPGD 917/4885 |
| US-20260125348-A1 | ARYL HYDROCARBON RECEPTOR ACTIVATORS | AHR, ARNT, NR1H2 | KDM4E 2619/4885ALDH1A1 2105/4885HPGD 2671/4885 |
| US-20100145054-A1 | IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | TYR, MCHR1, MCHR2 | KDM4E 220/4885ALDH1A1 448/4885HPGD 527/4885 |
| US-12473262-B2 | Aryl hydrocarbon receptor activators | AHR, ARNT, NR0B1 | KDM4E 2779/4885ALDH1A1 787/4885HPGD 917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.